Govt asks Serum, Bharat Biotech to lower price of Covid vaccines: Outline


The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their COVID-19 vaccines amid criticism from quite a lot of states who opposed to profiteering throughout this type of major crisis.

The issue of vaccine pricing was once discussed at a assembly chaired by Cabinet Secretary Rajiv Gauba.

Now the two companies are expected to get a hold of revised pricing for their vaccines.

The Hyderabad-based Bharat Biotech has constant the cost of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.

The Pune-based Serum Institute of India (SII), the world’s largest vaccine maker in relation to volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and Rs 600 per dose for private hospitals.

Both vaccines are to be had to the central government at a rate of Rs 150 per dose.

Many states have opposed to different prices of the vaccines, with Delhi Chief Minister Arvind Kejriwal saying this isn’t time for profiteering.

India has announced expansion of its COVID-19 vaccination drive by allowing its large 18-plus population to receive inoculated from May 1.

(Only the headline and picture of this outline may have been reworked by the Trade Standard staff; the remainder of the satisfied is auto-generated from a syndicated feed.)

Dear Reader,

Trade Standard has all the time strived tough to supply up-to-date information and observation on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and fixed feedback on how to toughen our offering have only made our get to the bottom of and commitment to these ideals stronger. Even throughout these difficult times arising out of Covid-19, we continue to remain dedicated to keeping you informed and up to date with credible news, authoritative views and incisive observation on topical issues of relevance.

We, on the other hand, have a request.

As we battle the economic have an effect on of the pandemic, we need your reinforce even more, in order that we will be able to continue to give you more quality satisfied. Our subscription mannequin has seen an encouraging response from many of you, who have subscribed to our online satisfied. More subscription to our online satisfied can only help us achieve the goals of offering you even better and more applicable satisfied. We imagine in free, reasonable and credible journalism. Your reinforce through more subscriptions can help us practise the journalism to which we are dedicated.

Enhance quality journalism and subscribe to Trade Standard.

Digital Editor

Top stories / News / Trade


Please enter your comment!
Please enter your name here